PPDDFU: Plantar Pressure Distribution in Diabetic Foot Ulcer

Sponsor
Cairo University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05888259
Collaborator
(none)
60
1
2
22
2.7

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to find out the changes in peak pressure and pressure-time integral after twelve weeks from the initial utility of foot insoles and eight weeks later as a follow-up in diabetic foot ulcers. Participants will be randomly assigned to foot insole, medication, and wound care (study group) or medication and wound care (control group).

Condition or Disease Intervention/Treatment Phase
  • Other: foot insole
N/A

Detailed Description

Insole design The foot insole is 5 mm thick under the flat part of the forefoot and the modification is done by changing the position of the metatarsal bar. This was another 5 mm above the flat part of the foot insole. The proximal/distal position of the metatarsal rod and the cavity distal to the rod (large cavity) were defined using the plantar pressure distribution. The position and shape of the distal end of the metatarsal bar were defined by a line in the area where the plantar pressure was 75% of the maximum plantar pressure. This line also defined the void's proximal border. The void's distal border was housed near the area of peak plantar pressures, where pressure was 10% of peak plantar pressure. The void measured 3 mm in depth. After completing the initial design of the metatarsal bars and void, two variations were created by relocating the metatarsal bar proximal and distal by 2-4% of the insole length depending on the position of the foot ulcer. Based on a previous pilot study, this proportion equates to a distance of 5-7 mm on a size 38 orthotic insole. The orthotic insoles were made of medium-density (Ethylene-vinyl acetate) EVA (50° Shore A) and were manufactured on a CNC machine.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Changes in Plantar Pressure Distribution After 12 Weeks of Foot Insole Utility in Diabetic Foot Ulcer Patients: a Prospective, Randomized, Double-blinded, Controlled Clinical Trial
Actual Study Start Date :
Sep 17, 2021
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Jul 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: foot insole, medication and wound care (study group)

Pressure maps were recorded to calculate peak pressures and pressure-time integrals for (hindfoot, middle foot, hallux, medial forefoot, and lateral forefoot). The measurements were uploaded to a server of software that uses technology to create a 3D model of the foot insole from multiple images taken by the user.

Other: foot insole
The foot insole is 5 mm thick under the flat part of the forefoot and the modification is done by changing the position of the metatarsal bar. This was another 5 mm above the flat part of the foot insole. The proximal/distal position of the metatarsal rod and the cavity distal to the rod (large cavity) were defined using the plantar pressure distribution. The position and shape of the distal end of the metatarsal bar were defined by a line in the area where the plantar pressure was 75% of the maximum plantar pressure The void measured 3 mm in depth.

Active Comparator: medication and wound care (control group)

participants will receive only medical treatments and wound care for the diabetic foot ulcer

Other: foot insole
The foot insole is 5 mm thick under the flat part of the forefoot and the modification is done by changing the position of the metatarsal bar. This was another 5 mm above the flat part of the foot insole. The proximal/distal position of the metatarsal rod and the cavity distal to the rod (large cavity) were defined using the plantar pressure distribution. The position and shape of the distal end of the metatarsal bar were defined by a line in the area where the plantar pressure was 75% of the maximum plantar pressure The void measured 3 mm in depth.

Outcome Measures

Primary Outcome Measures

  1. peak pressures [12 weeks]

    peak pressure for hindfoot, midfoot, hallux, medial and lateral forefoot

  2. pressure-time integrals [12 weeks]

    pressure time integral for hindfoot, midfoot, hallux, medial, and lateral forefoot

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
  • being between the ages of 50 and 65 years

  • males and females

  • with midfoot ulcer grades II or III

  • diabetic foot ulcer

  • the duration between 6 months and one year

  • diabetes mellitus incidence between seven and ten years

  • glycated hemoglobin between seven and nine (7 to 9%)

  • body mass index between 25 and 30 kg|m2

Exclusion Criteria:
  • Reynaud's disease

  • peripheral arterial disease

  • foot deformities

  • foot burns.

Contacts and Locations

Locations

Site City State Country Postal Code
1 faculty of physical therapy, Cairo University Giza Egypt 11432

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Ebtsam H Allam, PHD, Cairo University
  • Principal Investigator: Hany M Elgohary, PHD, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Hany Mohamed Ibrahim Elgohary, associate professor, Cairo University
ClinicalTrials.gov Identifier:
NCT05888259
Other Study ID Numbers:
  • F.P.T2207014
First Posted:
Jun 5, 2023
Last Update Posted:
Jun 5, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 5, 2023